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In recent years the use of endotoxins to alter the natural equilibrium between 
host and parasite has engendered many intriguing questions. One such problem 
of primary interest is whether the lethal and pyrogenic effects of these materials 
are necessarily related to their property of increasing resistance of the host to 
infection. With the development of a  relatively detoxified endotoxin, this sub- 
ject became amenable to direct investigation (1, 2). 
The  experiments reported in  this paper deal with  several properties of the 
detoxified derivative in stimulating host defense mechanisms as directly com- 
pared to the original endotoxin. The essentially equivalent capacity to acutely 
increase resistance  to various  bacterial infections has  been  demonstrated,  as 
well as the differences produced by varying the methods of treatment and in- 
fection. Studies dealing with the passive transfer of protection and the effects 
on the level of circulating leucocytes in the mouse are also discussed. 
Materials and Methods 
Animals.--Male mice of the ICR strain weighing 16 to 18 gm (Bellewood Farm, English- 
town, New Jersey) were housed 10 to a metal cage, fed Purina lab chow and water ad libitum. 
All animals were used routinely within 1 week after receipt. 
Bacterial Cultures.--Three representative Gram-negative bacteria were employed, includ- 
ing  strains  of  Escherichia  coli  and  Salmonella  typhimurium  previously  des- 
cribed (3) and a strain of Pseudomonas aeruginosa isolated in this laboratory. A  strain of 
Staphylococcus aureus (Smith) known to be virulent for mice was kindly provided by Dr. Ian 
M. Smith. Each organism was grown in brain heart infusion broth (BHI) (Difco Laboratories, 
Inc., Detroit) for 18 hours at 35°C prior to each experiment.  A standard inoculum was deter- 
mined for E. coli, Ps. aeruginosa, and S. aureus which produced 70 per cent to 80 per cent mor- 
tality within 3 days in those animals injected intraperitoneally.  In those mice infected with S. 
typhimurium,  half the deaths would occur within I day, or, with a smaller inoculum, by 3 days. 
In certain experiments,  an E. coli bacteremia was produced by intravenous injection of 0.25 
ml of an 18 hour culture into one of the tail veins, a dose which produced 90 per cent to 100 
per cent deaths within 3 days. For the Gram-negative cultures,  appropriate dilutions were 
made in sterile BHI broth. The staphylococcal culture was centrifuged,  the cells washed once, 
and resuspended  to their original volume in sterile saline. Viable numbers  of organisms were 
determined by triplicate plate counts on BHI agar. All inocula were kept chilled in an ice 
bath during the challenge procedure and 0.25 ml of the appropriate dilutions was used for 
intraperitoneal injections. 
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Endotoxin and Modified Fractions.--The Salmonella typhosa 0-901 endotoxin and the frac- 
tions obtained by acetylation  have been described in the previous report (2). Stock suspensions 
of each material were made at 1 mg/ml and stored at -20°C. Dilutions were made in non- 
pyrogenic saline immediately prior to the various pretreatment procedures.  All necessary 
precautions were taken to prevent contamination from extraneous pyrogen and cross-con- 
tamination from the parent endotoxin. 
Pretreatment Procedures.--The endotoxin  and fractions were administered 24 hours prior 
to challenge with the infecting  organism. In each experiment  the fractions were tested side 
by side with the endotoxin from which they were derived. For intraperitoneal pretreatment, 
the materials were incorporated in 1.0 ml volumes, while 0.2 ml volumes were used for all 
intravenous, intramuscular, and subcutaneous  injections.  Appropriate non-pyrogenic  saline 
injected controls were included to measure the virulence of the infecting  organism in each 
test. 
Serum and Plasma.--Treated and control mice were anesthetized with ether and exsan- 
guinated from the heart at the time when they ordinarily would be infected.  Serum was sep- 
arated from the clotted blood, pooled, and kept at -20°C. Plasma was collected by using 1 
volume of 3.8 per cent sodium citrate for  5 volumes of whole blood.  The blood cells were 
centrifuged  off and the pooled plasma stored at -20°C. In all cases, serum and plasma were 
used  within 1 week from  the day of collection  and injected intraperitoneaIly 30 minutes 
prior to the bacterial challenge injected by the same route. 
Leucocyte Counts.--Total peripheral white blood cell counts were made in mice pretreated 
by various routes with either the endotoxin  or its acetylated fraction. Blood samples were 
taken from one of the tail veins. Counts were made just prior to treatment and then at stated 
hourly intervals described below. 
EXPEEI~ENTAL 
Comparative  Studies of Endotoxin and Fractions  in Stimulating Resistance  to 
Bacterial Infeetions.--Previous work indicated that a suitable model for measur- 
ing the effects of endotoxin and endotoxin-like extracts on the acute modifica- 
tion of resistance to infection was that employed wherein mice were pretreated 
24 hours prior to a  standardized bacterial challenge (3-6). While no true linear 
dose response was found to exist in our experiments, effective doses could be 
determined within the experimental limits of this system. 
The degree of enhanced resistance induced by endotoxins, as well as being 
generally considered dependent on the level of the pretreatment and infective 
doses, and the time interval between such injections, is also known to be de- 
pendent  on  the route of inoculation  (7).  Since  the results using homologous 
inoculation routes have been consistent, this approach seemed appropriate for 
providing a  more sensitive system that might distinguish between protective 
and ineffective materials. 
Increased  Resistance  to  S.  typhimurium.--S,  typhosa  and  S.  typhimurium 
share  a  common  somatic  antigen  12,  according  to  the  Kauffmann-White 
schema (8). If the antigenic nature of the endotoxins plays a  role in the basic 
mechanism of the so called non-specific resistance to infection, and modifications 
of the O  antigen altered the common determinant groupings, the increased re- 
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consequently might be altered when using the fractions obtained after acetyl- 
ation.  With  this  in  mind,  S.  typhimurium  was  the  bacterial  challenge  first 
chosen to determine whether any of the modified fractions would possess im- 
munogenic activity. 
Although specific vaccines have been found to provide only a partial degree 
of immunity to S. typhimurium, nevertheless, increased resistance can be meas- 
ured  in  a  mouse typhoid infection system by the time  to reach  50 per  cent 
mortality (STso). The various fractions, P, L, and E, obtained after acetylation 
TABLE I 
Effect of Endotoxin Acetflated Fractions on the Survival of Mice Infected 
with Salmondla typhimurium 
Treatment*, 
1.0 ml ip 
Experiment 1 
Saline 
Endotoxin 
P 
L 
E 
Experiment 2 
Saline 
Endofoxin 
P 
E 
Saline~ 
L~ 
No. of bacteria 
per mouse ip 
1.7  X  107 
3.3 X 10  5 
cc 
2  3 
9  9 
0  1 
1  4 
7  9 
0  0 
0  0 
0  1 
0  0 
0  1 
0  2 
0  0 
Cumulative deaths, on days 
4  5  6 
0  0 
9  9 
6  6 
0  0 
1  2 
7  9 
5  9 
5  7 
4  6 
7  8 
6  6 
11  12  13  14 
10  10  10  10 
9  9  9  9 
8  9  9  9 
10  10  10  10 
7  7  7  7 
20  20 
17  17 
15  15 
15  15 
10  10 
9  9 
* 10 ~g per mouse of endotoxin or fraction. 
Tween 80 concentration, 0.05 per cent. 
as described (2), were compared at the same dose known to be effective for the 
original endotoxin. The results are summarized in Table I. 
In the first experiment, the endotoxin and detoxified P fraction increased the 
STb0 to 3 to 4 days, while the toxic E  fraction provided the same degree of re- 
sistance for 7 to 8 days. The L  fraction was ineffective; however, it was quite 
lyophobic, and the possibility remained that actual loss of material left on glass- 
ware  during dilution procedures may have affected the results.  Therefore,  a 
suitable surface-active agent, tween 80, was employed to aid in dispersing this 
particulate fraction. In a second experiment using a smaller bacterial challenge, 
the fractions were again compared to the original endotoxin. The results again 
serve  to  emphasize  the  protective  properties  inherent  to  the  detoxified  P 
fraction, while the L fraction was not significantly effective as compared to its 946  NON-SPECII~IC  HOST  RESISTANCE 
appropriate control. In two separate trials of 10 mice per group, the endotoxin, 
P, and E fractions increased the mean STs0 approximately 4 days. 
,- Increased Resistance to S. aureus.--Since, of the two detoxified fractions, only 
the P, henceforth referred to as the acetylated derivative, showed protection 
against S. typhimurium, this derivative was subjected to further study with in- 
fections usually considered heterologous to S. typhosa O-901. 
Two endotoxin preparations and their respective acetylated derivatives were 
tested at four dosage levels against an intraperitoneal challenge of S. aureus 
(Smith). The results with each endotoxin and its derivative were comparable in 
TABLE II 
Increased Resistance to Staphylococcus aureus in Mice after Pretreatment with Endotoxin  or 
Derivative 
Pretreatment  Dose,  ip  Deaths within !  wk.  Per cent 
materials  after infection*  survivors 
Saline 
Endotoxin 
c~ 
cc 
L~ 
Derivative 
~c 
c~ 
ct 
/tg 
0.1 
1.0 
10.0 
50.0 
0.1 
1.0 
10.0 
50.0 
19/30~ 
13/20 
13/20 
1/20 
1/2o 
12/20 
9/20 
0/20 
0/20 
37.0 
35.0 
35.0 
95.0 
95.0 
40.0 
55.0 
100.0 
100.0 
* Challenge dose given ip. 
Number of animals dead 
$ Number of animals challenged 
all cases and the combined data are presented in Table II. The data dearly indi- 
cate levels at which these materials do or do not increase resistance to virulent 
staphylococci. While a dose of 10 #g is effective for the endotoxin and derivative, 
1 #g or less provides no significant protection in either case. 
Increased Resistance to E. coli.--A more sensitive system for measuring early 
resistance was found to exist with an E. coli peritonitis. Several individual tests 
at doses varying from 0.01/zg to 10 #g per mouse were performed. The pooled 
data given in Table III indicate that while the level of protection was not of a 
high order at any of the doses used, there were significant responses in all of the 
treated groups in each test to denote a non-specific increase in resistance. How- 
ever, in no case was there a discernible pattern of significant differences between 
the derivative and endotoxin. To further substantiate this observation in this 
system, an E. coli bacteremia was studied, within the experimental design em- 
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While exploratory work revealed that higher doses of endotoxin and deriva- 
tive were needed by intravenous pretreatment and challenge, resistance could be 
dearly defined at at least two dosage levels. In this experiment, enhanced re- 
sistance was provided in two ways; i.e., by the prolongation of the survival time 
at one dose and by a significant increase in the number of survivors at a second 
dose 5-fold greater in magnitude. As shown in Table IV, at the end of 1 week 
the derivative and endotoxin at 50 gg protected 50 to 60 per cent of the chal- 
lenged animaIs, as compared directly to the survivorship in the saline group. A 
dose of 10 #g of either material provided an sTs0 of 3 days compared to less than 
TABLE III 
Increased Resistance to Esckerickia coli in Mice after Pretreatment with Endotoxin or Derivative 
Pretreatment  Dose, ip  Deaths within 1 wk.  Per cent 
materials  after infection*  survivors 
Saline 
Endotoxin 
~C 
gc 
Derivative 
~c 
0.01 
0.1 
1.0 
10.0 
0.01 
0.1 
1.0 
10.0 
55/7o~ 
7/20 
9/20 
14/4o 
1614o 
6/20 
9/20 
17140 
10/30 
21.4 
65.0 
55.0 
65.0 
60.0 
70.0 
55.0 
57.5 
66.7 
* Challenge dose given ip. 
Number of animals dead 
Number of animals challenged ' 
24 hours for the saline controls, although the final survival values in these ex- 
perimental groups did not significantly differ from the controls. Again, the lack 
of a significant difference between the endotoxin and its acetylated derivative 
in their ability to bolster host resistance was evident. 
Increased Resistance to Ps. aeruginosa.--Three  experimental trials were run 
with three individual derivative preparations, the first two of which were used 
in the previously described staphylococcal studies, and the third used exclusively 
with Ps. aeruginosa, to date. The data are summarized in Table V. In the first 
experiment, no difference appeared between the endotoxin and derivative, al- 
though none of the dosage levels failed to show a significant state of enhanced 
resistance.  In the second experiment, a parallelism of behavior was again ob- 
served in that protection was provided by both materials at 50 #g but not signifi- 
cantly at 10 #g or below. In the third experiment, dosages were chosen at 2.5- to 
5-fold increments in the range of 0.1 #g to 10.0 gg per animal. Individual com- 
parisons were determined with 7 to 10 mice per group. In this case, a difference 948  NON-SPECIFIC HOST  RESISTANCE 
between the materials may be observed not apparent with S.  aureus,  E.  coli, 
or the aforementioned trials with Ps. aeruginosa.  Critical doses at which the two 
materials deviated in their provocative activity occurred at 0.25 #g with the 
endotoxin, where protection was still significant, but below which no activity 
was detectable, However, with the derivative significant protection was meas- 
ured at 2.5 #g, and on the basis of five separate trials, a discrete but compara- 
tively partial level of increased resistance was evident at  1.0/~g.  From these 
data, the materials appeared to differ in potency by at least a factor of 4 but 
not more than lO-fold. While the first two experiments in this series were not as 
extensive as the third, it would seem that differences, if they existed in the first 
TABLE IV 
Increased Resistance to an Intravenou~ Challenge of Escherichia coli in Mice after Administration 
of Endotoxin or Derivative 
Pretreatment  Materials 
Saline 
Endotoxin 
¢c 
Derivative 
¢¢ 
Dose, iv 
~g 
lO 
50 
lO 
50 
Cumulative deaths, on days 
1  3  5 
8/10"  8/10  9/10 
4/lO  3/lO   /lO 
3/10  3/10  3/10 
4/lo  511o  811o 
3/10  4/10  4/10 
9/10 
7/10 
3/lo 
8/lo 
4/lo 
Per cent 
survivors 
10 
30 
70 
20 
60 
Number of animals dead 
Number of animals challenged 
two preparations,  would have been detected.  Furthermore,  since  the tests in 
these series were run at different times over a  period of several months, with 
consistent results in each case, the variations due to any changes in bacterial 
culture or the susceptibility of the mice to the effects of the materials under 
study would appear to be nullified.  Thus,  the more likely explanation would 
seem to be in the variation attributable to the acetylation procedure, thereby 
producing a derivative of somewhat lower potency. Whether the other infection 
system studies would respond in the same manner to a derivative of this type 
remains to be determined. 
The Effect of the Acetylated Derivative in Stimulating  Resistance by Means  of 
tteterologous  Pretreatment Routes.--Further  confirmation of the observations of 
Hook and Wagner (7) concerning the greater efficacy in protection when endo- 
toxin and challenge were injected by the same route in mice was obtained  in 
experiments employing heterologous inoculation routes and E.  coli as the in- 
fective challenge. Preliminary work indicated  a  larger dose of endotoxin  was BARN'ET  M.  SULTZER  AND  HENRY  H.  FREEDMAN  949 
necessary to provide a significant degree of survival in this type of system than 
that ordinarily employed for the intraperitoneal homologous route  technique. 
In order  to explore the efficacy of the derivative,  a  constant dose of both 
endotoxin and derivative was used, varying independently the injection routes 
of pretreatment and challenge but maintaining the usual 24 hour interval be- 
tween such injections. The data in Table VI summarize several trials for each 
procedure. No difference appeared between the endotoxin and derivative when 
TABLE V 
Increased Resistance to Pseudomonas aeruginosa in Mice after Administration of Endotoxin or 
Derivative 
Dose,  ip 
t~g 
Experiment 1 
1.0 
10.0 
50.0 
Experiment 2 
1.0 
10.0 
50.0 
Experiment 3 
0.10 
0.25 
1.0 
2.5 
10.0 
40 
60 
90 
Per cent survivors at 1 wk.* 
Endotoxin  Saline  Derivative 
0 (10)~ 
(10)  40 (10) 
(10)  70 (10) 
(lo) 
30 (10) 
lo (lo) 
60 (io) 
30 (20) 
65 (20) 
62 (50) 
90 (20) 
75 (28) 
* Challenge dose given lp. 
~; Total number of mice tested in parentheses. 
10 (10) 
18 (50) 
70 (10) 
30 (10) 
10 (10) 
60 (10) 
35 (2o) 
25 (20) 
42 (50) 
80 (2o) 
74 (27) 
they were given intraperitoneally or intramuscularly and the mice  were chal- 
lenged  with  an  intravenous  infection,  although  for  the  same dose and  time 
interval, the intramuscular route was less effective for both materials. When the 
mice were pretreated by the intravenous route, the derivative was found to be 
about one-half as active as the  endotoxin  to an E.  coli  peritonitis,  although 
when  the  animals were pretreated by the intramuscular  route no significant 
difference appeared with the same type of infection. 
The Effects of the  Transfer of Serum or Plasma from Treated Mice to Normal 
Mice Infected with E. coli.--Rowley has stated that early immunity can be trans- 
ferred by the serum of protected mice to normal mice (4, 9). Therefore, to de- 
termine whether protective antibody or some other humoral factor may play a 950  NON-SPECIFIC  HOST  RESISTANCE 
TABLE VI 
Increased Resistance to Escherichla coU in Mice after Pretreatment by Heterologous Inoculation 
Routes with Endotoxin or Derivative 
Materials injected  Pretreatment  Challenge  route  Deaths at 1 wk.  Per cent 
route*  after challenge  survivors 
Saline 
Endotoxin 
Derivative 
Saline 
Endotoxin 
Derivative 
Saline 
Endotoxin 
Derivative 
Saline 
Endotoxin 
Derivative 
ip 
¢¢ 
ct 
im 
4¢ 
iv 
im 
lg 
lg 
iv 
¢¢ 
¢¢ 
iv 
¢¢ 
t¢ 
ip 
gg 
¢¢ 
ip 
g¢ 
g¢ 
18/2o~ 
4/19 
6/20 
23/25 
15/25 
14/24 
18/2o 
6/20 
13/20 
23/25 
13/25 
17/25 
10.0 
78.9 
70.0 
8.0 
40.0 
41.7 
10.0 
70.0 
35.0 
8.0 
48.0 
32.0 
* 50 ~g dose,  see Materials and 
Number of animals dead 
Number of animals challenged " 
Methods  for injection volumes. 
TABLE VII 
Effects of Transfer of Serum or Plasma from  Treated Mice to Normal Mice on Resistance to 
Escherichia coli Infection 
Pretreatment  of donor mice*  Intraperitoneal  injection of  Deaths I wk. after 
recipient mice  challenge~ 
ml 
Experiment 1 
Saline 
Endotoxin, 10 gg 
Derivative, 10 gg 
Experiment 2 
Saline 
Endotoxin, 10 gg 
Derivative, 10 gg 
Experiment 3 
Saline 
Endotoxin, 50 ~tg 
Derivative, 50 ~tg 
Serum, O. 1 
Serum, O. 25 
Plasma, 0.25 
Ctt  ~lt 
¢¢  ¢g 
9/12§ 
8/12 
lO/lO 
lo/lo 
9/9 
lO/lO 
12/14 
14/15 
12/15 
* All injections iv, see Materials and Methods for further details. 
Challenge dose given ip 30 minutes after serum or plasma injection of normal recipients. 
Number of animals dead 
§ Number of animals challenged " BARNET  M.  SULTZER  AND  HENRy  H.  1;'REEDMAN  951 
role in the basic systems described above, somewhat akin to the passive transfer 
of phagocytosis stimulation and protection against endotoxin pyrogenicity and 
lethality described by Freedman (10),  the transfer of serum  or plasma from 
mice pretreated with endotoxin or derivative was done as described in Materials 
and Methods. 
In order to maintain a rigorously integrated system, the same endotoxin and 
derivative preparations used in the active immunity studies with E.  coli,  S. 
aureus, and the first trials with Ps. aeruginosa were employed here at two doses 
known to be effective for an E. coli peritonitis. The serum or plasma was taken 
at a time when the treated animals would ordinarily be challenged. The intra- 
peritoneal system was employed for the normal recipients of serum or plasma 
and the challenge. 
Total Mean Perlpkeral Leu¢o¢ 
TABLE VIII 
vtes in M~e after Trealment witk Endotoxin or Dedvative 
Treafm~n¢: 
Endotoxin, 50 t~g ip 
"  50 #g iv 
Derivative, 50 ~g ip 
"  50 #g iv 
Leucocyte count (thoussnds)/mmS, hrs. postinjectlon 
0  1  2  3  4  5  6  24 
14.2"  14.6  17.1  18.8  21.0  23.8  24.5  13.8 
14.0  14.7  19.7  21.8  24.6  30.1  34.0  34.2 
15.2  15.1  16.2  17.2  18.8  22.3  21.4  15.9 
15.0  16.5  21.0  24.4  37.3  37.6  40.8  35.8 
* 6  mice per group. 
The data of three experimental trials are presented in Table VII. Under these 
conditions, ndther serum nor plasma from treated mice increased resistance to 
a significant level. 
Tke Effects of Endotoxin and Derivative on tke Level of Circulating Leucocytes 
in tke Mouse.--The well documented effect of endotoxin on leucocyte mobiliza- 
tion was next investigated to determine whether the derivative maintained the 
capacity to cause the characteristic initial leucoperfia and subsequent leuco- 
cytosis found in rabbits after endotoxin treatment. Using a constant dose of S0 
/~g per mouse and varying the route of inoculation to coincide with the pro- 
tection models  described above,  the  numbers  of peripheral leucocytes were 
measured in mice at various time intervals after injection. A serial time study, 
as depicted in Table VIII, revealed several points of interest. 
Mter  an  intraperitoneal injection of endotoxin, a  gradual  increase  in  the 
number of white blood cells appeared which became significant at 3 hours. At 
24 hours, when such mice would have been infected, the leucocyte counts had 
returned to the normal level. The response to the derivative was similar,  al- 952  NON-SPF.CI~IC  HOST  RESISTANCE 
though a significant increase appeared somewhat later at 4 hours. On the other 
hand, after an intravenous inoculation,  both materials produced a sharp rise 
by the 2rid hour with a continual increase throughout the 6 hour test period. By 
the next day, the leucocyte levels were still at least 100 per cent higher than the 
preinjection counts. A 50/zg dose of these same materials given intraperitoneally 
will protect mice against E. coli given intravenously, although the level of circu- 
lating leucocytes is unchanged.  The same dose given intravenously will also 
protect against E. coli given intravenously or intraperitoneally when the leuco- 
cyte count is higher than normal. It would seem the mere quantitative account 
of the peripheral  leucocytes resulting from pretreatment with protective endo- 
toxin or derivative cannot, therefore,  independently reflect the increased  re- 
sistance of the host to infection with E. coli. It may be also emphasized that in 
such young mice of approximately 5 weeks of age, no leucopenia was evident. 
Other studies to be reported indicate that 3 month old mice do respond with a 
leucopenia  and leucocytosis  to  endotoxin  given  intravenously; however,  no 
leucopenia appears  when such mice are treated with the same dose of the de- 
rivative. Furthermore, 50 #g of either material administered subcutaneously 
into mice of both ages elicits a definitive leucocyte mobilization  at 24 hours 
equivalent to the intravenous response, although such animals are not protected 
against an intravenous or intraperitoneal challenge. 
DISCUSSION 
Where the technique of homologous inoculation routes was employed, a clear 
separation of the pyrogenic properties of endotoxin from its capacity to provoke 
increased  resistance  to infection may be observed.  Even if the reduction in 
pyrogenicity  of each of the derivatives is assumed to be 100-fold, the lower limit 
of the observed decrease (2), no comparable decrease in the resistance-increasing 
activity of the derivative is evident, for the activities of the endotoxin and its 
derivative in the experiments  with E. coli and S.  aureus infections are indu- 
bitably equivalent. This striking dissociation of these two biological effects also 
appears  in those assays involving Ps.  aeruginosa,  although a relatively small 
difference in activity between one derivative preparation and its parent endo- 
toxin was  detected.  Furthermore, in  those experiments  where  heterologous 
routes of injection were used, the similarity of the materials was maintained in 
all of the combinations, except where the derivative was given intravenously  and 
the host challenged intraperitoneally. However, again the reduction in activity 
in this case was insignificant compared to the decrease in pyrogenicity. 
The relative loss in toxicity of the specific derivatives compared to their 
parent endotoxins also must be considered in relation to the results  of the in- 
fection studies. While the LDs0 for the endotoxin  was 0.25 mg intraperitoneally, 
the derivative which was used  in those  studies  where  mice were pretreated 
intravenously  and challenged with E. coli by the same route, produced no deaths BARNET  M. SULTZER AND  HENRY  H.  FREEDMAN  953 
at a level of 2 mg per mouse  (2). Despite  this gross difference in toxicity, a 
marked parallel capacity of the two materials to differentially  alter the resistance 
to E. coli  existed at 2 dosage levels. Since the lethality of the derivative is a 
function of the route of injection and a dichotomy  in effects is obtained between 
the endotoxin and derivative when the intravenous route is employed, i.e. the 
endotoxin is more toxic and the derivative less toxic than when they are given 
intraperitoneally, the separation of the protective and lethal effects is even more 
apparent. Assuming the more toxic of the derivatives is typical (approximately 
an 8-fold reduction in lethality intraperitoneally), still, the only instance where 
lethality and the protective potency would not be clearly dissociated is the one 
experiment involving  Ps.  aeruginosa.  On  the other hand, with this same in- 
fection, other derivatives demonstrated parallel  protective properties to the 
parent endotoxin. Thus the weight of the available evidence indicates a distinct 
dissociation of the lethal and protective properties of endotoxin by the use of the 
acetylated derivative. 
In  the  experiments  concerned  with  the  effects  of  heterologous  injection 
routes,  there became evident the first indication that a significantly detectable 
difference in the protective capacity existed between the endotoxin and deriva- 
tive. This difference and the more particulate nature of the derivative suggest 
the possible alteration of its distribution within the host as compared to the un- 
modified endotoxin. In turn, this altered distribution may be related directly or 
otherwise to the primary organs infected by the pathogen. From the standpoint 
of the infecting agent, the fulminating peritonitis from an intraperitoneal in- 
jection (11) contrasts with the initial bacteremia and localization primarily in 
the liver  and spleen when the organisms  are introduced by the intravenous 
route (12). Thus, the fact that the derivative is as effective as endotoxin by the 
intravenous-intravenous, or intraperitoneal-intraperitoneal method, but less by 
the intravenous-intraperitoneal method, lends further support to the concept of 
primarily a  localized cellular  reaction that so alters  resistance  to provide a 
favorable outcome for the host. Furthermore, the finding that the derivative is 
even less lethal intravenously than intraperitoneally, contrary to the typical be- 
havior of endotoxin in this regard,  supports the probable  difference in its dis- 
tribution within the host. 
One aspect of a host cellular reaction to endotoxin administration has been 
the classical response of the number of circulating  leucocytes in rabbits. The 
course of leucopenia and leucocytosis has been repeatedly confirmed; however, 
the response characteristic for mice used in infection and resistance models has 
not received the same degree of systematic attention. Smith, el al. reported a 
peripheral  granulocytosis  in 3 to 4 month old mice 24 hours after 10/zg of S. 
typhosa endotoxin given intraperitoneally correlated  with increased resistance 
to a pseudomonad infection, although repeated endotoxin treatment produced a 
diminution in white blood cells closely approaching  the normal control level 954  NON-SPECIfIC  HOST  RESISTANCE 
while the increased resistance still persisted (13). In studying factors concerned 
with innate rather than acquired immunity, Gowen and Calhoun found the 
degree of resistance to S. ~yphimurium  in selected, resistant inbred mice to be 
correlated with the mean number of circulating leucocytes (14).  But Weir, et al. 
found mice bred for low leucocyte counts to be more resistant to the same mouse 
pathogen (15). In the system used in our experiments, a distinct lack of correla- 
tion existed between the level of circulating leucocytes after intraperitoneal or 
subcutaneous injection of endotoxin or derivative and the degree of resistance 
to an intravenous infection. The evidence from several viewpoints appears to 
indicate, then, that the total number of peripheral white blood cells does not 
contribute as a protective mechanism per se; it cannot be considered as an inde- 
pendent factor, and, rather, one must study, as has been done in vitro,  the 
qualitative  state  of  those phagocytic elements  which  are  part  of  the  total 
leucocyte response. 
The failure to obtain passive transfer of protection by plasma or serum of re- 
sistant mice to normal recipients can, of course, be ascribed to the methods 
employed, particularly in reference to the dosage schedule of serum or plasma. 
In the last study, mice were treated with endotoxin or derivative at 500 times 
that needed to demonstrate active protection, recipient mice received approxi- 
mately 25 per cent of their total blood fluid volume, and no protection was evi- 
dent. Nevertheless, the in ~vo dilution of the known low levels of measurable 
factors  such  as  specific  antibody or  opsonins may well have  obviated  any 
measurable in dvo protective response. 
In this connection, some preliminary findings concerning other attributes of 
the acetylated derivative are worth noting. In rabbits there is a diminution of 
from 5- to 10-fold in the specific agglutinin response to S. typhosa O-901 by the 
derivative  as  compared  to  its  endotoxin, although no  significant difference 
existed in the minimal stimulation of agglutinin to the E. coli strain used in our 
infection studies. The total dosages of each material were of the same order of 
magnitude as those used in the protection studies. Also, where as little as 1 #g 
of endotoxin given mice 30 minutes prior to an intraperitoneal dose of S. aureu~ 
increased the number of deaths due to the infection by 50 per cent, no such 
effect was produced by the derivative at 10 times the endotoxin dose. Thus, the 
derivative has lost a substantial degree of the capacity of the endotoxin to in- 
crease the susceptibility of mice to virulent bacteria. Studies are continuing as 
to these described effects and their bearing on present humoral and cellular 
hypotheses for explaining early nonspecific resistance (15-19). 
SUMMARY 
An acetylated derivative prepared from Salmonella  typhosa O-901 endotoxin 
has been found to retain the ability to stimulate non-specific host resistance to a 
variety of bacterial infections. Relative to the parent endotoxin, the derivative BARNET M'.  SULTZER AND HENRY H,  ~REEDMAN  955 
has been reduced in the gross in its pyrogenicity to rabbits and lethality to mice. 
With the use of this chemically modified preparation  under a variety of con- 
ditions,  the direct dissociation of the  toxic properties  of endotoxin from its 
protective capacity appears evident. 
In young male mice, the endotoxin and its derivative produced a leucocytosis 
but no leucopenia. However, no direct correlation could be found with the level 
of the peripheral white blood cells and resistance to infection with Escherichia 
coll. Furthermore, under the conditions employed, passive transfer of early re- 
sistance to infection by serum or plasma was not detectable. 
The authors wish to acknowledge  the excellent technical assistance of Amain Brahm and 
Miriam Graft. 
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